Skip to main content
OpenTrials

Clinical trial condition

Myositis

Explore clinical trials studying Myositis. Study availability and eligibility vary by location and protocol.

155 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Myositis trial results

Recruiting

Descartes-08 in Autoantibody Myositis

NCT07391605

Conditions
Antisynthetase Syndrome, Antisynthetase syndrome, Muscular Diseases, +4 more
Locations
  • University of California, Irvine Orange, California, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • National Neuromuscular Research Institute Austin, Texas, United States
View Trial Details
Recruiting

Adult and Juvenile Myositis

NCT00017914

Conditions
Connective Tissue Diseases, Dermatomyositis, Inclusion Body Myositis, +9 more
Locations
  • Emory University Atlanta, Georgia, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • NIEHS Clinical Research Unit (CRU) Research Triangle Park, North Carolina, United States
  • Texas Scottish Rite Hospital Dallas, Texas, United States
View Trial Details
Recruiting

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

NCT07103746

Conditions
Autoimmune Diseases, Autoimmune Disorders, Immune System Diseases, +5 more
Locations
  • University of Alabama at Birmingham School of Medicine: Division of Clinical Immunology & Rheumatology Birmingham, Alabama, United States
  • Emory University School of Medicine: Division of Rheumatology Atlanta, Georgia, United States
  • University of Chicago, Department of Medicine: Rheumatology Chicago, Illinois, United States
  • Johns Hopkins Hospital: Division of Rheumatology Baltimore, Maryland, United States
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Manning Family Children's Hospital of New Orleans New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

NCT06733935

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, +23 more
Locations
  • Nkarta Investigational Site Orange, California, United States
  • Nkarta Investigational Site Gainesville, Florida, United States
  • Nkarta Investigational Site Miami, Florida, United States
  • Nkarta Investigational Site Plantation, Florida, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

NCT07085104

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +24 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

NCT06991114

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +29 more
Locations
  • Artiva Investigational Site Tuscaloosa Tuscaloosa, Alabama, United States
  • Artiva Investigational Site Phoenix Phoenix, Arizona, United States
  • Artiva Investigational Site Tucson Tucson, Arizona, United States
  • Artiva Investigational Site Chula Vista Chula Vista, California, United States
View all 52 locations
View Trial Details
Recruiting

A Study of AZD0120 in Autoimmune Diseases

NCT07295847

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Stanford, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Ann Arbor, Michigan, United States
View all 22 locations
View Trial Details
Recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

NCT06916806

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +17 more
Locations
  • Research Site Anniston, Alabama, United States
  • Research Site Birmingham, Alabama, United States
  • Research Site La Jolla, California, United States
  • Research Site Sacramento, California, United States
View all 37 locations
View Trial Details

Related conditions